Crossmark

Liver microphysiological systems development guidelines for safety risk assessment in the pharmaceutical industry

Crossref DOI link: https://doi.org/10.1039/C9LC00768G

Published Online: 2020

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Baudy, Andreas R. https://orcid.org/0000-0001-5588-6855
Otieno, Monicah A.

Hewitt, Philip

Gan, Jinping https://orcid.org/0000-0002-7072-7614
Roth, Adrian

Keller, Douglas https://orcid.org/0000-0002-6186-2881
Sura, Radhakrishna

Van Vleet, Terry R.

Proctor, William R.
License Information

Accepted Manuscript valid from 2020-11-20
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Andreas R. Baudy (ORCID)

: Jinping Gan (ORCID)

: Douglas Keller (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 5 August 2019; Accepted 20 November 2019; Accepted Manuscript published 20 November 2019; Advance Article published 4 December 2019; Version of Record published 21 January 2020